% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Moser:307435,
author = {R. Moser and L. M. Buchecker and J. Nano and N. A. Mayr and
S. T. Behzadi and S. Kiesl and S. Maier and L. Allwohn and
J. Lammert$^*$ and L. C. Adams and M. Tschochohei and S. E.
Combs$^*$ and K. J. Borm},
title = {{A}ttitudes {T}owards {L}arge {L}anguage {M}odel-based {AI}
{S}ystems as an {I}nformation {S}ource for {S}hared
{D}ecision {M}aking in {R}adiation {O}ncology.},
journal = {The oncologist},
volume = {nn},
issn = {1083-7159},
address = {Oxford},
publisher = {Oxford University Press},
reportid = {DKFZ-2025-03034},
pages = {nn},
year = {2025},
note = {epub},
abstract = {Implementing structured shared decision making (SDM)
requires high-quality, reliable patient information. In
radiation oncology, patients often have limited knowledge
and misconceptions about therapy and side effects, affecting
their decision-making. Large Language Model-based AI systems
(LLMs) may help by providing evidence-based information in
accessible language, but successful implementation depends
on the willingness of patients and health care professionals
(HCPs) to adopt these technologies.A survey was conducted
among patients undergoing radiation therapy and HCPs between
03/2024-02/2025. Data was collected using structured
electronic questionnaires (32 items for patients, 35 for
HCPs). The survey assessed sociodemographic characteristics,
the status of SDM in oncology, sources of information
relevant to SDM, and current and anticipated LLM
applications. Data were analyzed using descriptive
statistics and logistic regression analysis.The internet was
the prime information source for patients (n = 400).
Regarding current use of LLMs, a large discrepancy between
patients and HCPs (n = 200) was observed $(18.2\%$ vs.
$69.5\%).$ Although $77\%$ of HCPs believed that patients
will rely on LLMs in the future, only $29.1\%$ of patients
agreed. Most patients $(65.8\%)$ stated that even as LLMs
improve, they will continue to trust physicians more; $46\%$
of HCPs shared this view. Only $16.5\%$ of patients were
convinced that LLMs provide all relevant data for SDM in
cancer care. Familiarity with technology was the strongest
predictor of LLM use among patients.Only a minority of
radiation oncology patients currently use LLMs, and many
remain skeptical about their future role-contrasting with
the more optimistic expectations of HCPs.},
keywords = {ChatGPT (Other) / Large Language Models (LLMs) (Other) /
artificial intelligence (AI) (Other) / cancer care (Other) /
radiotherapy (Other) / shared decision making (SDM) (Other)},
cin = {MU01},
ddc = {610},
cid = {I:(DE-He78)MU01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41429565},
doi = {10.1093/oncolo/oyaf414},
url = {https://inrepo02.dkfz.de/record/307435},
}